Initial in vivo evidence for a potential disconnect between ARF and p53 came from the finding that combined p19Arf and p53 deficiency in mice results in the emergence of a tumor spectrum consisting of a wider range of tumor types than in mice lacking either gene alone [9]. Here, TP53 is linked to neoplasm.